Vaccine maker Indian Immunologicals (IIL) has started construction of its new, Rs.700 crore veterinary vaccine manufacturing facility in Hyderabad’s Genome Valley.
Foot and mouth disease vaccine (FMD-Vac) as well as combined foot and mouth disease-haemorrhagic septicaemia vaccine (FMD+HS-Vac) will be manufactured at the plant. “The brand-new unit will have a BSL3 facility for the manufacture of drug substances and a fill-finish capability for the production of both drug products of FMD vaccine and the FMD+HS vaccine,” the National Dairy Development Board (NDDB) subsidiary IIL said after the ground breaking ceremony on December 28.
The plant will have a capacity of 300 million doses per annum - 150 million each of the two vaccines. The facility, to come up on a 14 acre land parcel at Biotech Park, Phase III, Karkapatla allotted by Telangana State Industrial Infrastructure Corporation (TSIIC), is expected to create more than 750 direct and indirect jobs.
